InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by Hansard Adam, Directeur Commercial. Officer active across 1 companies, notably Applied Therapeutics Inc.. Aggregated, 8 reports have been published. Total volume traded: €87k. The latest transaction was filed on 14 December 2021 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
031,700 shares0
Common Stock
SEC:0001209191-22-002968·
031,700 shares0
Common Stock
SEC:0001209191-22-002964·
031,700 shares0
Common Stock
SEC:0001209191-22-002968:0·
031,700 shares0
Common Stock
SEC:0001209191-22-002964:0·
031,700 shares0
Common Stock
SEC:0001209191-21-070086·
031,700 shares0
Common Stock
SEC:0001209191-21-070086:0·
€43,5552,894 shares@ €15.0501100.0% of flow
Common Stock
SEC:0001209191-21-036685·
€43,5552,894 shares@ €15.050150.0% of flow
Common Stock
SEC:0001209191-21-036685:0·
8 of 8 declarations
About Hansard Adam
Adam Hansard is the Chief Commercial Officer at Applied Therapeutics Inc. He is responsible for the company's commercial strategy, aiming to maximize growth opportunities and strengthen the company's market position. Adam brings expertise in marketing and business development, contributing to the development of effective strategies to achieve the company's objectives. His experience in the biotechnology sector enables him to navigate a competitive environment and make informed decisions for the company's future.
